M. S. Orr

发表

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

Hanlee P. Ji, G. M. Fischer, Stephen C. Harris, 2006, Nature biotechnology.

An Important Role for the Retinoblastoma Protein in Staurosporine-induced G1 Arrest in Murine Embryonic Fibroblasts*

W. Reinhold, M. S. Orr, P. O'Connor, 1998, The Journal of Biological Chemistry.

Ionizing Radiation and Teniposide Increase p 21 waf 1 / cip 1 and Promote Rb Dephosphorylation but Fail to Suppress E 2 F Activity in MCF-7 Breast Tumor Cells

M. S. Orr, D. Gewirtz, J. Randolph, 1997 .

Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells.

M. S. Orr, D. Gewirtz, J. Randolph, 1997, Molecular pharmacology.

Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status.

M. S. Orr, D. Gewirtz, Y. Di, 1997, International journal of radiation biology.

Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells.

K. Kohn, M. S. Orr, P. O'Connor, 2000, Journal of the National Cancer Institute.

Biomarkers of tobacco smoke exposure.

William Mattes, Xi Yang, Donna L Mendrick, 2014, Advances in clinical chemistry.

Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line

M. S. Orr, D. Gewirtz, J. Randolph, 1998, Cancer Chemotherapy and Pharmacology.

Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin.

M. S. Orr, D. Gewirtz, J. Randolph, 1996, Biochemical pharmacology.

Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells.

M. S. Orr, D. Gewirtz, J. Randolph, 1998, Biochemical pharmacology.

Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells.

M. S. Orr, L. Povirk, D. Gewirtz, 1994, Biochemical pharmacology.

Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.

M. S. Orr, J. Cleveland, C. Rodríguez-Galindo, 2001, Biochemical pharmacology.

High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors

M. S. Orr, Y. Kuryshev, Zhiqi Liu, 2017, SLAS discovery : advancing life sciences R & D.

Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26.

M. S. Orr, D. Gewirtz, J. Randolph, 1995, Biochimica et biophysica acta.

Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future

Michael S Orr, M. S. Orr, 2014, Tobacco Control.

Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin.

M. S. Orr, D. Gewirtz, J. Randolph, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Evaluation of external RNA controls for the assessment of microarray performance

Weida Tong, Huixiao Hong, Leming Shi, 2006, Nature Biotechnology.

UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase*

E. Sausville, M. S. Orr, P. O'Connor, 1998, The Journal of Biological Chemistry.

Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.

M. S. Orr, L. Povirk, D. Gewirtz, 1993, Cancer research.

The Experience with Voluntary Genomic Data Submissions at the FDA and a Vision for the Future of the Voluntary Data Submission Program

S. Amur, M. S. Orr, F. Goodsaid, 2007, Clinical pharmacology and therapeutics.

Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors

M. S. Orr, Y. Kuryshev, Zhiqi Liu, 2016, Assay and drug development technologies.

Toxicogenomics and Cross-Species Biomarker Discovery: Applications in Drug Discovery and Safety Assessment

M. S. Orr, 2006, Toxicology mechanisms and methods.

Homology Model and Ligand Binding Interactions of the Extracellular Domain of the Human α4β2 Nicotinic Acetylcholine Receptor

Weida Tong, Huixiao Hong, Heng Luo, 2016 .

Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death.

M. S. Orr, D. Gewirtz, N. C. Watson, 1996, International journal of radiation biology.

Damage and Alterations in Gene Expression Breast Tumor Cell Line : Evidence for Induction of Gene-specific Antiproliferative Activity of Teniposide ( VM-26 ) in the MCF-7 Dissociation between Bulk Damage to DNA and the Updated Version

M. S. Orr, L. Povirk, D. Gewirtz, 2006 .